Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Economic evaluation of subcutaneous versus intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy: a real-life study.
Piscitelli E, Massa M, De Martino BM, Serio CS, Guglielmi G, Colacicco G, Tuccillo F, Habetswallner F. Piscitelli E, et al. Among authors: habetswallner f. Eur J Hosp Pharm. 2021 Nov;28(Suppl 2):e115-e119. doi: 10.1136/ejhpharm-2020-002430. Epub 2020 Oct 29. Eur J Hosp Pharm. 2021. PMID: 33122403 Free PMC article.
ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-zeolite to prevent Chemotherapy-Induced Side Effects, in particular, Peripheral Neuropathy.
Vitale MG, Barbato C, Crispo A, Habetswallner F, Martino BM, Riccardi F, Maione A, Eisenwagen S, Vitale G, Cartenì G. Vitale MG, et al. Among authors: habetswallner f. Molecules. 2020 May 13;25(10):2297. doi: 10.3390/molecules25102297. Molecules. 2020. PMID: 32414185 Free PMC article. Clinical Trial.
Lessons from peculiar cases of anaphylaxis: why allergists should be prepared for the unexpected.
Liccardi G, Milanese M, Bilò MB, Martini M, Liccardi MV, Gargano D, Giordano A, Habetswallner F, Lo Schiavo M, Madonna F, Montera MC, Pane G, Papa A, Pedicini A, Rogliani P. Liccardi G, et al. Among authors: habetswallner f. Eur Ann Allergy Clin Immunol. 2022 May;54(3):99-106. doi: 10.23822/EurAnnACI.1764-1489.198. Epub 2021 Apr 15. Eur Ann Allergy Clin Immunol. 2022. PMID: 33939345 Free article. Review.
Italian recommendations for the diagnosis and treatment of myasthenia gravis.
Evoli A, Antonini G, Antozzi C, DiMuzio A, Habetswallner F, Iani C, Inghilleri M, Liguori R, Mantegazza R, Massa R, Pegoraro E, Ricciardi R, Rodolico C. Evoli A, et al. Among authors: habetswallner f. Neurol Sci. 2019 Jun;40(6):1111-1124. doi: 10.1007/s10072-019-03746-1. Epub 2019 Feb 18. Neurol Sci. 2019. PMID: 30778878
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
37 results